New hope for tough cancers: experimental drug IMGS-001 enters human trials
Disease control
Recruiting now
This early-stage trial tests an experimental drug called IMGS-001 in people with advanced solid tumors that have returned or stopped responding to standard treatments. The study has two parts: first, finding a safe dose, then testing that dose in specific cancers like ovarian can…
Phase: PHASE1 • Sponsor: ImmunoGenesis • Aim: Disease control
Last updated May 04, 2026 16:18 UTC